文献速递贫血与红细胞疾病白血病淋巴瘤

范可尼贫血与共济失调毛细血管扩张症患儿的癌症风险:德国全国注册队列研究

Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany.
PubMed 文献 · J Clin Oncol · 2021-10-01

该研究基于德国DNA修复缺陷参考实验室与儿童癌症注册数据,纳入1973至2020年诊断的421例范可尼贫血(FA)和160例共济失调毛细血管扩张症(AT)患者,评估儿童期癌症风险。FA患儿癌症风险增加39倍(SIR=39,95%CI 26-56),髓系肿瘤SIR达445;AT患儿风险增加56倍(SIR=56,95%CI 33-88),霍奇金淋巴瘤SIR为215,非霍奇金淋巴瘤SIR为470。约11%的FA和14%的AT患者在18岁前发生癌症。

要点

  • FA患儿儿童期癌症风险显著增高,髓系肿瘤风险尤为突出。
  • AT患儿儿童期癌症风险以淋巴瘤为主,非霍奇金淋巴瘤风险极高。
  • FA和AT患儿18岁前癌症累积发生率分别约11%和14%。

核心结论

  • FA和AT患儿儿童期癌症风险较一般人群显著增加,FA以髓系肿瘤为主,AT以淋巴瘤为主。

研究设计与样本

  • 基于德国DNA修复缺陷参考实验室和德国儿童癌症注册的全国注册队列研究,纳入1973至2020年诊断的421例FA和160例AT患者。

主要发现

  • 421例FA患者中观察到33例儿童期癌症,预期0.74例,SIR=39(95%CI 26-56)。
  • FA患者髓系肿瘤癌症特异性SIR=445(95%CI 272-687)。
  • 160例AT患者中观察到19例儿童期癌症,预期0.32例,SIR=56(95%CI 33-88)。
  • AT患者霍奇金淋巴瘤癌症特异性SIR=215(95%CI 58-549),非霍奇金淋巴瘤SIR=470(95%CI 225-865)。

关键数值与推荐

  • FA患者儿童期癌症SIR=39(95%CI 26-56),髓系肿瘤SIR=445(95%CI 272-687)。
  • AT患者儿童期癌症SIR=56(95%CI 33-88),霍奇金淋巴瘤SIR=215(95%CI 58-549),非霍奇金淋巴瘤SIR=470(95%CI 225-865)。
  • 约11%的FA患者和14%的AT患者在18岁前发生癌症。

临床怎么用

  • 对FA和AT患儿应加强癌症监测,尤其关注FA的髓系肿瘤和AT的淋巴瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fanconi anemia (FA) and ataxia-telangiectasia (AT) are rare inherited syndromes characterized by abnormal DNA damage response and caused by pathogenic variants in key DNA repair proteins that are also relevant in the pathogenesis of breast cancer and other cancer types. The risk of cancer in children with these diseases is poorly understood and has never been assessed in a population-based cohort before. METHODS: We identified 421 patients with FA and 160 patients with AT diagnosed between 1973 and 2020 through German DNA repair disorder reference laboratories. We linked patients' laboratory data with childhood cancer data from the German Childhood Cancer Registry. RESULTS: Among 421 patients with FA, we observed 33 cases of childhood cancer (15 cases of myelodysplastic syndrome; seven cases of acute myeloid leukemia; two cases of lymphoma, carcinoma, medulloblastoma, and nephroblastoma, respectively; and one case of rhabdomyosarcoma, acute lymphoblastic leukemia, and glioma, respectively) versus 0.74 expected (on the basis of population-based incidence rates in Germany). This corresponds to a 39-fold increased risk (standardized incidence ratio [SIR] = 39; 95% CI, 26 to 56). For all FA subgroups combined, the cancer-specific SIR for myeloid neoplasms was 445 (95% CI, 272 to 687). Among the 160 patients with AT, we observed 19 cases of childhood cancer (15 cases of lymphoma, three cases of leukemia, and one case of medulloblastoma) versus 0.32 expected. This corresponds to a 56-fold increased risk (SIR = 56; 95% CI, 33 to 88). The cancer-specific SIR for Hodgkin lymphoma was 215 (95% CI, 58 to 549) and for non-Hodgkin lymphoma 470 (95% CI, 225 to 865). CONCLUSION: Approximately 11% of patients with FA and 14% of patients with AT develop cancer by age 18 years.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Dutzmann CM, Spix C, Popp I, et al. Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany. J Clin Oncol. 2021. PMID: 34597127. doi:10.1200/JCO.21.01495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。